Chronic disease management focuses on symptom control and enhancing the patient’s overall quality of life.
ACE inhibitors are commonly used as first-line therapy, particularly in patients with diabetes or kidney disease.
An A1C of 9% is above target levels, and insulin therapy may be required to achieve better glucose control.
Nitrofurantoin is commonly recommended for uncomplicated UTIs due to its effectiveness and low resistance rates.
Tachycardia and hypotension indicate possible systemic infection and sepsis, requiring urgent evaluation.
